A client presents to the Women's Health Clinic for continuation of her contraceptive method. She has been using Depo-Provera (medroxyprogesterone acetate) for 24 months. In preparation for instituting a plan of care,
the nurse would consider which option as a priority?
a. Schedule the client for follow-up baseline diagnostic testing to confirm that the client is not pregnant.
b. Obtain information for an alternate contraception method.
c. Ask the client for additional information related to her menstrual cycle.
d. Inspect the skin for site selection of contraceptive method.
ANS: B
According to WHO (World Health Organization) guidelines, women should not be on Depo-Provera for more than 2 years because of bone density loss. Therefore, the nurse should include assessments for other types of contraception methods for the client. Although it may prove to be important to rule out possible pregnancy, based on the provided information, discontinuation of this method is the priority intervention. Depo-Provera can cause menstrual irregularities, but this is not the priority intervention. The nurse can follow up on this issue later. Because the current method of contraception should no longer be used, this option is not necessary.
You might also like to view...
An 81-year-old patient with congestive heart failure has been sent to a cardiologist who prescribes digoxin (Lanoxin) 0.125 mg PO every morning. The pharmacy dispenses pills that contain 0.25 mg of Lanoxin
How many pills should the nurse teach the patient to take every morning? A) 2 B) 1.5 C) 1 D) 0.5
During a skin assessment, the nurse notes an extravasation of blood into the skin layers that was caused by an injury. Which is most appropriate when documenting this finding?
1) Ecchymosis 2) Petechiae 3) Purpura 4) Telangiectasia
The toddler
A. is able to interact and play with other children of the same age. B. does not know the difference between right and wrong. C. may react with frustration and other misbehavior if disciplined. D. becomes sexually curious.
When planning care for a patient who is receiving filgrastim (Neupogen) for a nonmyeloid malignancy, the nurse should formulate which of the following patient outcomes? (Select all that apply.)
A) The patient will not develop an infection. B) The patient will not experience bone pain. C) The patient will be able to self-administer filgrastim at home. D) The patient will not develop febrile neutropenia. E) The patient will not retain fluid.